Genes Encoding the Virulence and the Antimicrobial Resistance in Enterotoxigenic and Shiga-toxigenic E. coli Isolated from Diarrheic Calves
Authors:
Open Access
Abstract
Calf diarrhea is one of the considerable infectious diseases in calves, which results in tremendous economic losses globally. To determine the prevalence of Shiga-toxigenic E. coli (STEC) and Enterotoxigenic E. coli (ETEC) incriminated in calf diarrhea, with special reference to Shiga- toxins genes (stx1 and stx2) and enterotoxins genes (lt and sta) that govern their pathogenesis, as well as the virulence genes; eaeA (intimin) and f41(fimbrial adhesion), and the screening of their antibiogram and antimicrobial resistance genes; aadB, sul1, and bla-TEM, a total of 274 fecal samples were collected (April 2018–Feb 2019) from diarrheic calves at different farms in El-Sharqia Governorate, Egypt. The bacteriological examination revealed that the prevalence of E. coli in diarrheic calves was 28.8%. The serotyping of the isolated E. coli revealed 7 serogroups; O26, O128, O111, O125, O45, O119 and O91. Furthermore, the Congo red binding test was carried out, where 89.8% of the examined strains (n = 71) were positive. The antibiogram of the isolated strains was investigated; the majority of E. coli serotypes exhibit multidrug resistance (MDR) to four antimicrobial agents; neomycin, gentamycin, streptomycin, and amikacin. Polymerase chain reaction (PCR) was used to detect the prevalence of the virulence genes; stx1, stx2 lt, sta, f41 and eaeA, as well as the antimicrobial resistance genes; aadB, sul1, and bla-TEM. The prevalence of STEC was 20.2% (n = 16), while the prevalence of ETEC was 30.4% (n = 24). Briefly, the Shiga toxins genes; stx1 and stx2, are the most prevalent virulence genes associated with STEC, which are responsible for the pathogenesis of the disease and helped by the intimin gene (eaeA). In addition, the lt gene is the most prevalent enterotoxin gene accompanied by the ETEC strains, either alone or in combination with sta and/or f41 genes. The majority of pathogenic E. coli incriminated in calf diarrhea possesses the aadB resistance gene, followed by the sul1 gene. Enrofloxacin, florfenicol, amoxicillin-clavulanic acid, and ampicillin-sulbactam, are the most effective antimicrobial agents against the isolated STEC and ETEC strains.Keywords
Funding Information
- King Saud University (RSP-2019/53)
This publication has 42 references indexed in Scilit:
- Prevalence and Molecular Epidemiological Characterization of Antimicrobial-Resistant Escherichia coli Isolates from Japanese Black Beef CattleJournal of Food Protection, 2013
- Multidrug resistant commensal Escherichia coli in animals and its impact for public healthFrontiers in Microbiology, 2013
- Genetic Diversity and Antimicrobial Resistance of Escherichia coli from Human and Animal Sources Uncovers Multiple Resistances from Human SourcesPLOS ONE, 2011
- Escherichia coli O157:H7: Animal Reservoir and Sources of Human InfectionFoodborne Pathogens and Disease, 2011
- Human Infections with Non-O157 Shiga Toxin–producingEscherichia coli, Switzerland, 2000–2009Emerging Infectious Diseases, 2011
- Molecular basis of virulence in clinical isolates of Escherichia coli and Salmonella species from a tertiary hospital in the Eastern Cape, South AfricaGut Pathogens, 2011
- Virulence factors inEscherichia coliisolated from calves with diarrhea in VietnamJournal of Veterinary Science, 2011
- Comparison of electrocardiographic parameters and serum electrolytes and microelements between single infection of rotavirus and coronavirus and concurrent infection of Cryptosporidium parvum with rotavirus and coronavirus in diarrheic dairy calvesComparative Clinical Pathology, 2010
- Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotypeJournal of Antimicrobial Chemotherapy, 2010
- Serotypes, Virulence Genes, and Intimin Types ofShiga Toxin (Verotoxin)-ProducingEscherichia coliIsolatesfrom Cattle in Spain and Identification of a New Intimin VariantGene(eae-ξ)Journal of Clinical Microbiology, 2004